PRC medical instruments company in H-share placement

    May 13, 2011 | BY

    Candice Mak

    PRC medical products supplier Shandong Weigao Medical Polymer Company has raised HK$1.8 billion (US$227 million) in connection with its placement of new…

    PRC medical products supplier Shandong Weigao Medical Polymer Company has raised HK$1.8 billion (US$227 million) in connection with its placement of new H-shares. The proceeds will be used to build a new production plant.

    The joint global coordinators, joint bookrunners and joint placing agents were China International Capital Corporation and Morgan Stanley.

    Acting for the Hong Kong-listed issuer was a Troutman Sanders Hong Kong team led by Shirley Lau and Joe Sevack.

    This premium content is reserved for
    China Law & Practice Subscribers.

    • A database of over 3,000 essential documents including key PRC legislation translated into English
    • A choice of newsletters to alert you to changes affecting your business including sector specific updates
    • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
    For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]